Testosterone and TRT: What Science Shows About the Hormone, Deficiency, and Replacement Therapy
Testosterone sits at the center of many discussions about men's health, performance, and aging. Yet worlds separate sober medicine from online hype: testosterone replacement therapy (TRT) is an established, prescription-only treatment for a clearly diagnosed deficiency – not a lifestyle tool for general optimization. This article explains how testosterone works physiologically, when hypogonadism is said to be present, and what high-quality studies actually demonstrate about benefits, risks, and the long-running heart debate. It is purely educational and does not replace a medical evaluation; diagnosis and therapy belong in the hands of specialist physicians.
Machine-assisted translation. The German original is the authoritative version.
Key points
- Testosterone is the central male sex hormone and is controlled via a finely tuned control loop.
- Hypogonadism is only diagnosed when matching symptoms AND repeatedly, clearly low values come together.
- TRT is an approved, prescription-only medicine for a proven deficiency – not an optimization tool for healthy people.
- The TRAVERSE study (2023) found no increased rate of major cardiovascular events versus placebo in diagnosed deficiency.
- Diagnosis, therapy selection, and monitoring belong exclusively in medical hands.
What testosterone is and how it is regulated
Testosterone is the most important male sex hormone (androgen). It is produced predominantly in the testes, in smaller amounts also in the adrenal cortex – and it occurs in low concentrations in the female body as well. Its physiological tasks include the development of male sex characteristics, the maintenance of muscle and bone mass, sperm formation, the regulation of libido, as well as influences on mood, energy, and metabolism.
Its release follows a control loop (the hypothalamic-pituitary-gonadal axis): the hypothalamus releases GnRH, the pituitary gland then secretes LH and FSH, which in turn stimulate the testes to produce testosterone. When the testosterone level rises, the body throttles the higher-level signals via negative feedback – a self-regulating system. Testosterone levels also fluctuate over the course of the day and are typically highest in the morning, which is why measurements in the morning and while fasting are recommended.
- Most important male androgen, produced mainly in the testes
- Regulated via the hypothalamic-pituitary-gonadal axis with negative feedback
- Affects muscles, bones, sperm formation, libido, and metabolism
- Levels fluctuate with the time of day and are highest in the morning
Hypogonadism: when a genuine deficiency is present
Hypogonadism is the term used when the body produces too little testosterone and typical complaints are present at the same time. Professional societies explicitly emphasize that neither a low lab value alone nor symptoms alone are sufficient: a diagnosis requires matching signs and symptoms plus repeatedly and clearly low testosterone levels. The Endocrine Society guideline recommends first determining the morning total testosterone while fasting using a reliable method and confirming an abnormal value with a second measurement.
Physicians broadly distinguish two forms: primary hypogonadism (the cause lies in the testes themselves) and secondary hypogonadism (the disorder is located in the hypothalamus or pituitary gland). This distinction is important because it points to different causes and guides the further evaluation. Possible symptoms include, among others, declining libido, erectile dysfunction, fatigue, low mood, loss of muscle mass, or reduced bone density – yet all of this is nonspecific and can have many other causes. Precisely for this reason, a careful medical evaluation is indispensable before any therapy is considered.
- Diagnosis only with symptoms AND repeatedly, clearly low values
- Morning, fasting measurement; an abnormal value must be confirmed
- Primary (testes) vs. secondary (hypothalamus/pituitary) hypogonadism
- Symptoms are nonspecific and need medical interpretation
TRT: a prescription-only therapy, not an optimization tool
Testosterone replacement therapy (TRT) supplies the body with testosterone from outside in order to compensate for a proven deficiency. Testosterone-containing medicines are approved, prescription-only drugs in Germany and the EU. Authorities such as the European Medicines Agency (EMA) explicitly state that these agents should only be used when the testosterone deficiency is confirmed by signs and symptoms as well as laboratory tests – and that levels must be checked regularly during treatment.
This clearly sets medical TRT apart from the online hype that promotes testosterone as a general anti-aging or performance agent for healthy men. An important physiological point: when testosterone is supplied from outside, the body throttles its own production via negative feedback, which can, among other things, impair sperm formation and thus fertility – an aspect particularly relevant for younger men who wish to have children and one that must be discussed with a physician. Out of editorial caution, this article deliberately names no dosages, preparations, application schemes, or sources of supply; these decisions are made solely by the treating physician.
- An approved, prescription-only medicine – not a lifestyle product
- According to the EMA, only for a confirmed deficiency and with regular monitoring
- Supply from outside can suppress the body's own production and fertility
- Diagnosis, selection, and monitoring belong in medical hands
Benefits, risks, and the heart debate: what research shows
In correctly diagnosed hypogonadism, TRT can relieve symptoms such as loss of libido and favorably influence parameters such as muscle and bone mass. For years, however, the question loomed of whether testosterone increases the risk of cardiovascular events. As early as 2014, a review procedure by the EMA concluded that there was no consistent evidence of an increased heart risk – the indications were weak and not clear-cut – but it called for further research.
The most informative answer to date was provided in 2023 by the large, randomized, placebo-controlled TRAVERSE study, published in the New England Journal of Medicine. It enrolled more than 5,000 men with hypogonadism and existing or elevated cardiovascular risk. The result: TRT was not inferior to placebo with regard to major cardiovascular events (about 7.0% versus 7.3%). This means: within the carefully selected group of people studied, there was no increased risk of such events. It does not mean that TRT would be safe or sensible for healthy men without a deficiency. At the same time, the study observed indications of other risks such as atrial fibrillation – one more reason for medical monitoring. Overall, the rule is: the data support safety with use as intended, but do not replace an individual benefit-risk assessment.
- EMA 2014: no consistent evidence of an increased heart risk
- TRAVERSE 2023 (NEJM): TRT not inferior to placebo for major cardiac events
- The statement applies to diagnosed deficiency, not to healthy men
- Indications of other risks (e.g., atrial fibrillation) require monitoring
Putting the hype into perspective
Online, testosterone is often portrayed as a universal key to muscles, energy, and youth – not infrequently combined with self-tests, gray-market sources, and the claim that every tired or exhausted man has a deficiency requiring treatment. This narrative is not medically tenable. Fatigue, lack of drive, or declining libido are nonspecific and more often caused by lack of sleep, stress, excess weight, illnesses, or medications than by a genuine hormone deficiency.
The decisive difference lies between a guideline-compliant therapy for a confirmed hypogonadism and the uncontrolled use as a supposed optimization tool. Taking testosterone without a secured indication can suppress the body's own production, impair fertility, and cause side effects – without any proven benefit for healthy people. Anyone who suspects symptoms in themselves should therefore not rely on self-experiments but seek a medical evaluation.
- "Every tired man has a testosterone deficiency" is a claim, not a fact
- Nonspecific symptoms usually have other causes
- Use without an indication brings risks without proven benefit
- If suspected: medical evaluation instead of self-experimentation
Related substance profiles
Frequently asked questions
- Does low testosterone automatically mean I need therapy?
- No. A single low lab value is not enough. Professional societies require matching symptoms together with repeatedly and clearly low values measured in the morning and while fasting. Many complaints such as fatigue or loss of libido have other causes. Only a medical evaluation can clarify whether a deficiency requiring treatment is present at all.
- Is TRT harmful to the heart?
- This was disputed for a long time. In 2014, the EMA found no consistent evidence of an increased heart risk. The large TRAVERSE study of 2023 showed, in men with diagnosed deficiency and cardiovascular risk, that TRT was not inferior to placebo for major cardiac events. This safety applies to use as intended in a genuine deficiency, not to healthy men without an indication, and does not replace an individual medical assessment.
- Can I use testosterone for general performance enhancement?
- This is not advisable. Testosterone-containing agents are prescription-only medicines that are only intended for a confirmed deficiency. In healthy men, a proven benefit is lacking, while risks such as suppressed self-production and impaired fertility are real. PeptidLotse provides no dosages or application instructions here – such questions belong in a conversation with a physician.
Sources
- New England Journal of MedicineCardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE)Clinical trial
- The Journal of Clinical Endocrinology & Metabolism (Oxford Academic)Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice GuidelineReview
- European Medicines Agency (EMA)PRAC review does not confirm increase in heart problems with testosterone medicinesAuthority / regulatory
- ClinicalTrials.govTRAVERSE: A Study of the Effect of Testosterone Replacement Therapy on the Incidence of Major Adverse Cardiovascular Events (NCT03518034)Clinical trial
This article is for information and education only. It does not replace medical advice and deliberately contains no dosing, usage or sourcing information.

